Abstract
Vanadium salts influence the activities of a number of mammalian enzymes in vitro but the mechanisms by which low concentrations of vanadium ameliorate the effects of diabetes in vivo remain poorly understood. The hypothesis that vanadium compounds act by inhibiting protein tyrosine phosphatases has attracted most support. The studies described here further evaluate the possibility that vanadyl sulfate trihydrate (VS) can also inhibit 3′,5′-cyclic adenosine monophosphate (cAMP) dependent protein kinase (PKA). Using conventional assay conditions, VS inhibited PKA only at high concentrations (IC50>400 μM); however, PKA inhibition was seen at dramatically lower concentrations of VS (IC50<10 μM) when sequestration of vanadyl ions was minimized. Vanadyl appears to be the effective PKA inhibitor because sodium orthovanadate did not inhibit PKA and inhibition by vanadyl was abolished by potential chelators such as ethylenediaminetetraacetic acid or glycyl peptides. PKA inhibition by vanadyl appears to be mixed rather than strictly competitive or uncompetitive and may replicate the inhibitory effects of high concentrations of Mg2+. The effect of vanadyl on PKA provides a possible explanation for the effects of vanadium salts on fat tissue lipolysis and perhaps on other aspects of energy metabolism that are controlled by cAMP-dependent mechanisms. Considering the high degree of conservation of the active sites of protein kinases, vanadyl may also influence other members of this large protein family.
Similar content being viewed by others
Abbreviations
- BMOV:
-
Bis(maltolato)oxovanadium(IV)
- BSA:
-
Bovine serum albumin
- cAMP:
-
3′,5′-Cyclic adenosine monophosphate
- DTT:
-
Dithiothreitol
- EDTA:
-
Ethylenediaminetetraacetic acid
- EGTA:
-
Ethyleneglycol bis(β-aminoethylether)tetraacetic acid
- EPR:
-
Electron paramagnetic resonance
- GSH:
-
Reduced glutathione
- K :
-
Equilibrium constant
- k cat :
-
Catalytic constant
- K i :
-
Competitive inhibition constant
- \( {K}\ifmmode{'}\else$'$\fi_{{\text{i}}} \) :
-
Uncompetitive inhibition constant
- K m :
-
Michaelis–Menten constant
- MES:
-
2-(N-Morpholino)ethanesulfonic acid
- OV:
-
Sodium orthovanadate
- PDE:
-
Cyclic nucleotide phosphodiesterase
- PI3K:
-
Phosphatidylinositol 3′-OH kinase
- PKA:
-
Cyclic AMP dependent protein kinase
- SEM:
-
Standard error of the mean
- STZ:
-
Streptozotocin
- UBC:
-
University of British Columbia
- VS:
-
Vanadyl sulfate trihydrate
References
Goldwaser I, Gefel D, Gershonov E, Fridkin M, Shechter Y (2000) J Inorg Biochem 80:21–25
Cam MC, Brownsey RW, McNeill JH (2000) Can J Physiol Pharmacol 78:829–847
Heyliger CE, Tahiliani AC, McNeill JH (1985) Science 227:1474–1477
Cohen N, Halberstam M, Shlimovich P, Chang CJ, Shamoon H, Rosetti L (1995) J Clin Invest 95:2501–2509
Goldfine AB, Simonson DC, Folli F, Patti ME, Kahn CR (1995) J Clin Endocrinol Metab 80:3311–3320
Swarup G, Cohen S, Garbers DL (1982) Biochem Biophys Res Commun 107:1104–1109
Fantus IG, Deragon G, Lai R, Tang S (1995) Mol Cell Biochem 153:103–112
Posner BI, Faure R, Burgess JW, Bevan AP, Lachance D, Zhang-Sun G, Fantus IG, Ng JB, Hall DA, Lum BS Shaver A (1994) J Biol Chem 269:4596–4604
Eriksson JW, Lonnroth P, Smith U (1992) Diabetologia 35:510–516
Fantus IG, Ahmad F, Deragon G (1994) Diabetes 43:375–383
Gresser MJ, Tracey AS (1990) In: Chasteen ND (ed) Vanadium in biological systems, physiology and biochemistry. Kluwer, Dordrecht, pp 63–79
Huyer G, Liu S, Kelly J, Moffat J, Payette P, Kennedy B, Tsaprailis G, Gresser MJ Ramachandran C (1997) J Biol Chem 272:843–851
Green A (1986) Biochem J 238:663–669
Mooney RA, Bordwell KL, Luhowskyj S, Casnellie JE (1989) Endocrinology 124:422–429
Strout HV, Vicario PP, Saperstein R, Slater EE (1989) Endocrinology 124:1918–1924
Venkatesan N, Avidan A, Davidson MB (1991) Diabetes 40:492–498
Pandey SK, Madhu BA-S, Srivastava AK (1998) Biochemistry 37:7006–7014
Brownsey RW, Dong GD (1995) Mol Cell Biochem 153: 131–137
Fantus IG, Tsiani E (1998) Mol Cell Biochem 182:109–119
Post RL, Hunt DP, Walderhaug MO, Perkins RC, Park JH, Beth AH (1979) In: Skou JC, Noerby JG (eds) Proceedings of the international conference on the properties and functions of Na, K-ATPase: Academic, London, pp 389–401
Shechter Y, Karlish SJ (1980) Nature 284:556–558
Loten EG, Sneyd JG (1970) Biochem J 120:187–193
Degerman E, Smith CJ, Tornqvist H, Vasta V, Belfrage P, Manganiello VC (1990) Proc Natl Acad Sci USA 87:533–537
Ueki H, Okuhama R, Sera M, Inoue T, Tominaga N, Morita T (1992) Endocrinology 131:441–446
Castan I, Wijkander J, Manganiello V, Degerman E (1999) Biochem J 339:281–289
Pluskey S, Mahroof-Tahir M, Crans DC, Lawrence DS (1997) Biochem J 321:333–339
Ramanadham S, Brownsey RW, Cros GH, Mongold JJ, McNeill JH (1989) Am J Physiol 257:H904–H911
Marzban L, Rahimian R, Brownsey RW, McNeill JH (2002) Endocrinology 143:4636–4645
Chasteen ND (1981) In: Berliner LJ, Reuben J (eds) Biological magnetic resonance, vol 3. Plenum, New York, pp 53–119
Tachez M, Theobald F (1980) Acta Crystallogr B 36:2873–2880
Theobald F, Galy J (1973) Acta Crystallogr B 29:2732–2736
Rodbell M (1964) J Biol Chem 239:375–380
Severson DL, Denton RM, Bridges BJ, Randle PJ (1976) Biochem J 154:209–224
Stansbie D, Brownsey RW, Crettaz M, Denton RM (1976) Biochem J 160:413–416
Thomas JA, Schlender KK, Larner J (1968) Anal Biochem 25:486–499
Casnellie JE (1991) Methods Enzymol 200:115–120
Cornish-Bowden A (1995) In: Fundamentals of enzyme kinetics. Portland, London, pp 94–112
Cornish-Bowden A (1995) In: Analysis of enzyme kinetic data. Oxford University Press, Oxford, pp 3–198
Chasteen ND (1983) Struct Bonding 53:105–159
Crans DC, Tracey AS (1998) In: Tracey AS, Crans DC (eds) Vanadium compounds: chemistry, biochemistry, and therapeutic applications. ACS symposium series 711. American Chemical Society, Washington, DC, pp 2–29
Chasteen ND, Francavilla J (1976) J Phys Chem 80:867–871
Smith RM, Martell AE (1974) In: Smith RM, Martell AE (eds) Critical stability constants, vol 1. Plenum, New York, pp 204–211, 269–272
Crans DC, Bunch RL, Theisen LA (1989) J Am Chem Soc 111:7597–7607
Thompson KH, McNeill JH, Orvig C (1999) Chem Rev 99:2561–2572
Hanson GR, Sun Y, Orvig C (1996) Inorg Chem 35:6507–6512
Hengge AC (1998) In: Sinnott M (ed) Comprehensive biological catalysis, vol 1. Academic, New York, pp 517–542
Zheng J, Knighton DR, Eyck LFT, Karlsson R, Xuong NH, Taylor SS, Sowadski JM (1993) Biochemistry 32:2154–2161
Granot J, Mildvan AS, Hiyama K, Kondo H, Kaiser ET (1980) J Biol Chem 255:4569–4573
Nechay BR, Nanninga LB, Nechay PS (1986) Arch Biochem Biophys 251:128–138
Smith RM, Martell AE (1976) In: Smith RM, Martell AE (eds) Critical stability constants, vol 4. Plenum, New York, pp 1–14, 104–112
Francavilla J, Chasteen ND (1975) Inorg Chem 14:2860–2862
Crans DC, Smee JJ, Gaidamauskas E, Yang L (2004) Chem Rev 104:849–902
Labonnette D (1988) J Chem Res S:92–93
Domingo JL (2002) Biol Trace Elem Res 88:97–112
Benabe JE, Echegoyen LA, Pastrana B, Martinez-Maldonado M (1987) J Biol Chem 262:9555–9560
Acknowledgements
We thank Grant Mauk and Federico Rosell (Department of Biochemistry and Molecular Biology, UBC) for help with EPR spectroscopy and Chris Orvig and Nicholas Aebischer (Department of Chemistry, UBC) for selected EPR studies and the supply of vanadium compounds. Finally, we thank John McNeill and members of his laboratory (Faculty of Pharmaceutical Sciences, UBC) for many helpful discussions. This work was supported by an operating grant from the Canadian Institutes of Health Research (to R.W.B.) and a UBC graduate fellowship (to K.A.J.).
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Jelveh, K.A., Zhande, R. & Brownsey, R.W. Inhibition of cyclic AMP dependent protein kinase by vanadyl sulfate. J Biol Inorg Chem 11, 379–388 (2006). https://doi.org/10.1007/s00775-006-0087-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-006-0087-8